Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study.
PDF (1.1M)
Journal: 1984/August - British medical journal (Clinical research ed.)
ISSN: 0267-0623
PUBMED: 6428548
Abstract:
A case-control study of gall stone disease in women in relation to use of contraceptives, reproductive history, and concentrations of endogenous hormones was undertaken. The study population comprised 200 hospital patients with newly diagnosed gall stone disease, 182 individually matched controls selected from the community, and 234 controls who were patients in hospital. Use of oral contraceptives was associated with an increased risk of developing gall stones among young subjects but a decreased risk among older subjects. The risk of developing gall stone disease increased in association with increasing parity, particularly among younger women. The risk fell with increasing age at first pregnancy, independent of parity. Mean urinary excretion over 24 hours of oestrone, but not of pregnanediol, was significantly (p less than 0.05) greater for postmenopausal patients than controls. The age dependence of the relative risk associated with exposure to oral contraceptives and pregnancy suggests that there are subpopulations of women susceptible to early formation of gall stones after exposure to either oral contraceptives or pregnancy.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(29)
References
(39)
Diseases
(1)
Chemicals
(2)
Organisms
(1)
Processes
(3)
Similar articles
Articles by the same authors
Discussion board
Br Med J (Clin Res Ed) 288(6433): 1795-1799
PMID: 6428548

Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study.

Abstract

A case-control study of gall stone disease in women in relation to use of contraceptives, reproductive history, and concentrations of endogenous hormones was undertaken. The study population comprised 200 hospital patients with newly diagnosed gall stone disease, 182 individually matched controls selected from the community, and 234 controls who were patients in hospital. Use of oral contraceptives was associated with an increased risk of developing gall stones among young subjects but a decreased risk among older subjects. The risk of developing gall stone disease increased in association with increasing parity, particularly among younger women. The risk fell with increasing age at first pregnancy, independent of parity. Mean urinary excretion over 24 hours of oestrone, but not of pregnanediol, was significantly (p less than 0.05) greater for postmenopausal patients than controls. The age dependence of the relative risk associated with exposure to oral contraceptives and pregnancy suggests that there are subpopulations of women susceptible to early formation of gall stones after exposure to either oral contraceptives or pregnancy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 1795
1795
icon of scanned page 1796
1796
icon of scanned page 1797
1797
icon of scanned page 1798
1798
icon of scanned page 1799
1799

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Brett M, Barker DJ. The world distribution of gallstones. Int J Epidemiol. 1976 Dec;5(4):335–341. [PubMed] [Google Scholar]
  • Friedman GD, Kannel WB, Dawber TR. The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis. 1966 Mar;19(3):273–292. [PubMed] [Google Scholar]
  • Comess LJ, Bennett PH, Burch TA. Clinical gallbladder disease in Pima Indians. Its high prevalence in contrast to Framingham, Massachusetts. N Engl J Med. 1967 Oct 26;277(17):894–898. [PubMed] [Google Scholar]
  • Wheeler M, Hills LL, Laby B. Cholelithiasis: a clinical and dietary survey. Gut. 1970 May;11(5):430–437.[PMC free article] [PubMed] [Google Scholar]
  • Thistle JL, Eckhart KL, Jr, Nensel RE, Nobrega FT, Poehling GG, Reimer M, Schoenfield LJ. Prevalence of gallbladder disease among Chippewa Indians. Mayo Clin Proc. 1971 Sep;46(9):603–608. [PubMed] [Google Scholar]
  • Bernstein RA, Werner LH, Rimm AA. Relationship of gallbladder disease to parity, obesity, and age. Health Serv Rep. 1973 Dec;88(10):925–936.[PMC free article] [PubMed] [Google Scholar]
  • Williams CN, Johnston JL, Weldon KL. Prevalence of gallstones and gallbladder disease in Canadian Micmac Indian women. Can Med Assoc J. 1977 Oct 8;117(7):758–760.[PMC free article] [PubMed] [Google Scholar]
  • Ahlberg J. Serum lipid levels and hyperlipoproteinaemia in gallstone patients. Acta Chir Scand. 1979;145(6):373–377. [PubMed] [Google Scholar]
  • Honoré LH. Cholesterol cholelithiasis in adolescent females: its connection with obestiy, parity, and oral contraceptive use--a retrospective study of 31 cases. Arch Surg. 1980 Jan;115(1):62–64. [PubMed] [Google Scholar]
  • Layde PM, Vessey MP, Yeates D. Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics. J Epidemiol Community Health. 1982 Dec;36(4):274–278.[PMC free article] [PubMed] [Google Scholar]
  • Richardson JD, Scutchfield FD, Proudfoot WH, Benenson AS. Epidemiology of gallbladder disease in an Appalachian community. Health Serv Rep. 1973 Mar;88(3):241–246.[PMC free article] [PubMed] [Google Scholar]
  • Sampliner RE, Bennett PH, Comess LJ, Rose FA, Burch TA. Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. N Engl J Med. 1970 Dec 17;283(25):1358–1364. [PubMed] [Google Scholar]
  • Smith DA, Gee MI. A dietary survey to determine the relationship between diet and cholelithiasis. Am J Clin Nutr. 1979 Jul;32(7):1519–1526. [PubMed] [Google Scholar]
  • Diehl AK, Stern MP, Ostrower VS, Friedman PC. Prevalence of clinical gallbladder disease in Mexican-American, Anglo, and black women. South Med J. 1980 Apr;73(4):438–443. [PubMed] [Google Scholar]
  • Stolley PD, Tonascia JA, Tockman MS, Sartwell PE, Rutledge AH, Jacobs MP. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol. 1975 Sep;102(3):197–208. [PubMed] [Google Scholar]
  • Vessey M, Doll R, Peto R, Johnson B, Wiggins P. A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci. 1976 Oct;8(4):373–427. [PubMed] [Google Scholar]
  • Everson RB, Byar DP, Bischoff AJ. Estrogen predisposes to cholecystectomy but not to stones. Gastroenterology. 1982 Jan;82(1):4–8. [PubMed] [Google Scholar]
  • Bennion LJ, Knowler WC, Mott DM, Spagnola AM, Bennett PH. Development of lithogenic bile during puberty in Pima indians. N Engl J Med. 1979 Apr 19;300(16):873–876. [PubMed] [Google Scholar]
  • Scragg RK, McMichael AJ, Baghurst PA. Diet, alcohol, and relative weight in gall stone disease: a case-control study. Br Med J (Clin Res Ed) 1984 Apr 14;288(6424):1113–1119.[PMC free article] [PubMed] [Google Scholar]
  • Gough MH. "The cholecystogram is normal" ... but ... Br Med J. 1977 Apr 9;1(6066):960–962.[PMC free article] [PubMed] [Google Scholar]
  • Goldberg BB, Harris K, Broocker W. Ultrasonic and radiographic cholecystography. A comparison. Radiology. 1974 May;111(2):405–409. [PubMed] [Google Scholar]
  • deGraaft CS, Dembner AG, Taylor KJ. Ultrasound and false normal oral cholecystogram. Arch Surg. 1978 Jul;113(7):877–879. [PubMed] [Google Scholar]
  • Arcomano JP, Schwinger HN, DeAngelis J. The spontaneous disappearance of gall stones. Am J Roentgenol Radium Ther Nucl Med. 1967 Mar;99(3):637–641. [PubMed] [Google Scholar]
  • Margulies SI, Brogdon BG, Sindler RA, Perilla FR. Disappearing gall-stones. Br J Radiol. 1967 Jul;40(475):546–548. [PubMed] [Google Scholar]
  • Gray R. Disappearing gallstones: report of 2 cases. Br J Surg. 1974 Feb;61(2):101–103. [PubMed] [Google Scholar]
  • Metcalf MG. Are 24-hour urine collections necessary for the measurement of steroid excretion rates? N Z Med J. 1976 Aug 25;84(570):150–153. [PubMed] [Google Scholar]
  • Feinstein AR. Methodologic problems and standards in case-control research. J Chronic Dis. 1979;32(1-2):35–41. [PubMed] [Google Scholar]
  • Greenland S, Neutra R. An analysis of detection bias and proposed corrections in the study of estrogens and endometrial cancer. J Chronic Dis. 1981;34(9-10):433–438. [PubMed] [Google Scholar]
  • Everson GT, McKinley C, Lawson M, Johnson M, Kern F., Jr Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology. 1982 Apr;82(4):711–719. [PubMed] [Google Scholar]
  • Dökert B, Jaross W, Schentke KU, Trübsbach A, Sarembe B. Schwangerschaft, orale hormonale Kontrazeption und Gallenlipidzusammensetzung. Dtsch Gesundheitsw. 1978;33(25):1153–1155. [PubMed] [Google Scholar]
  • Cole P, MacMahon B, Brown JB. Oestrogen profiles of parous and nulliparous women. Lancet. 1976 Sep 18;2(7986):596–599. [PubMed] [Google Scholar]
  • Trichopoulos D, Cole P, Brown JB, Goldman MB, MacMahon B. Estrogen profiles of primiparous and nulliparous women in Athens, Greece. J Natl Cancer Inst. 1980 Jul;65(1):43–46. [PubMed] [Google Scholar]
  • Bennion LJ, Ginsberg RL, Gernick MB, Bennett PH. Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med. 1976 Jan 22;294(4):189–192. [PubMed] [Google Scholar]
  • Bennion LJ, Mott DM, Howard BV. Oral contraceptives raise the cholesterol saturation of bile by increasing biliary cholesterol secretion. Metabolism. 1980 Jan;29(1):18–22. [PubMed] [Google Scholar]
  • Lynn J, Williams L, O'Brien J, Wittenberg J, Egdahl RH. Effects of estrogen upon bile: implications with respect to gallstone formation. Ann Surg. 1973 Oct;178(4):514–524.[PMC free article] [PubMed] [Google Scholar]
  • Yen SS, Martin PL, Burnier AM, Czekala NM, Greaney MO, Jr, Callantine MR. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women. J Clin Endocrinol Metab. 1975 Mar;40(3):518–521. [PubMed] [Google Scholar]
  • Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women. Clin Endocrinol (Oxf) 1978 Jul;9(1):59–66. [PubMed] [Google Scholar]
  • Kirschner MA, Ertel N, Schneider G. Obesity, hormones, and cancer. Cancer Res. 1981 Sep;41(9 Pt 2):3711–3717. [PubMed] [Google Scholar]
  • Nordin BE, Crilly RG, Marshall DH, Barkworth SA. Oestrogens, the menopause and the adrenopause. J Endocrinol. 1981;89 (Suppl):131P–143P. [PubMed] [Google Scholar]
Copyright notice
Abstract
A case-control study of gall stone disease in women in relation to use of contraceptives, reproductive history, and concentrations of endogenous hormones was undertaken. The study population comprised 200 hospital patients with newly diagnosed gall stone disease, 182 individually matched controls selected from the community, and 234 controls who were patients in hospital. Use of oral contraceptives was associated with an increased risk of developing gall stones among young subjects but a decreased risk among older subjects. The risk of developing gall stone disease increased in association with increasing parity, particularly among younger women. The risk fell with increasing age at first pregnancy, independent of parity. Mean urinary excretion over 24 hours of oestrone, but not of pregnanediol, was significantly (p less than 0.05) greater for postmenopausal patients than controls. The age dependence of the relative risk associated with exposure to oral contraceptives and pregnancy suggests that there are subpopulations of women susceptible to early formation of gall stones after exposure to either oral contraceptives or pregnancy.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.